MedTrace Logo

Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy

NCT04080375 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-09-06

No results posted yet for this study

Summary

The aim of the study is to compare the effectiveness of vaginal dinoprostone 3 mg versus placebo before myomectomy to decrease blood loss during and after the operation.

Conditions

  • Myomectomy

Interventions

DRUG

Dinoprostone 3 mg

the patient will take one vaginal tablet of 3 mg dinoprostone 1 hour before surgery

DRUG

placebo

the patient will take one vaginal tablet of placebo 1 hour before surgery

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • AHMED SAMY · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2019-11-30
Completion
2019-12-10

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04080375 on ClinicalTrials.gov